Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Zelos Therapeutics logo — company profile

Zelos Therapeutics

Founded 2000 3 employees Venture round Total: $57.80M Health Care, Health and Wellness +1

General Information

Company Name Zelos Therapeutics
Founded Year 2000
Employees 3
Industries Health Care, Health and Wellness, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Zelos Therapeutics. To contact Zelos Therapeutics, visit zelostherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Zelos Therapeutics compare?

A PDF of Zelos Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Zelos Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Zelos Therapeutics

Zelos Therapeutics is a company specializing in innovative treatments for bone disorders and related indications in large, underserved markets. Led by an experienced team of biopharmaceutical executives and funded by leading health care investors, Zelos is advancing a portfolio of product opportunities in Phase 2 and 3 with significant commercial potential into late-stage clinical trials. The company is pursuing programs linked by the common mechanism of stimulating bone formation – specifically parathyroid hormone (PTH) analogs - to provide therapeutic benefit in key indications including osteoporosis, orthopedics, and renal bone disease. Established in 2000, Zelos Therapeutics operates within the Health Care, Health and Wellness, and Pharmaceutical industries. Their last investment was a $2.80M Venture Round investment at 15 August 2011.

Business keywords: biopharmaceutical, bone disorders, parathyroid hormone analogs, osteoporosis, orthopedics, renal bone disease, clinical trials, health care, investors, therapeutic treatments, phase 2 and 3, commercial potential

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $2.80M -
15 Aug 2011
Series B $42.50M 4
Alta Partners Frazier Healthcare Partners SR One
Alta Partners, Frazier Healthcare Partners +2
19 May 2005
Series A $11.70M 3
Genesys Capital Management Inc Seaflower Ventures
Genesys Capital Management Inc, Seaflower Ventures +1
01 Jan 2003
Seed Round $800.00K -
01 Dec 2001

Zelos Therapeutics Alternatives & Competitors

View All Alternatives
Zelos Therapeutics vs
Allena Pharmaceuticals, Inc.
Allena Pharmaceuticals, Inc. United States

Developing Therapeutics for Patients with Rare and Severe Metabolic and Kidney Disorders

Post-IPO Equity
13 employees
Biotechnology, Health and Wellness
Zelos Therapeutics vs
Zetagen Therapeutics
Zetagen Therapeutics United States

Founded in 2015, Zetagen is a private, clinical-stage, biopharmaceutical company dedicated to drivin...

Series B
11 employees
Health Care, Health and Wellness
Zelos Therapeutics vs
TransPharma Medical
TransPharma Medical

Pioneering transdermal drug delivery to enhance therapeutic outcomes for osteoporosis and other pept...

Series C
Biotechnology, Health Care
View all alternatives

FAQ About Zelos Therapeutics

Zelos Therapeutics specializes in the development of innovative treatments for bone disorders and related indications in large, underserved markets. Led by an experienced team of biopharmaceutical executives and funded by leading health care investors, Zelos is advancing a portfolio of product oppor...
Zelos Therapeutics was founded in 2000.
Zelos Therapeutics operates in Health Care, Health and Wellness and Pharmaceutical. Its work centres on biopharmaceutical, bone disorders, parathyroid hormone analogs and osteoporosis.
Zelos Therapeutics has approximately 3 employees.
Zelos Therapeutics has completed 4 funding rounds, raising a total of $57.80M. The latest funding stage is Venture round.
Top alternatives and competitors to Zelos Therapeutics include Allena Pharmaceuticals, Inc., Zetagen Therapeutics, TransPharma Medical, Courage Therapeutics, Nymox Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Zelos Therapeutics and Allena Pharmaceuticals, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Zelos Therapeutics, https://bouncewatch.com/company/zelos-therapeutics, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout